Literature DB >> 15220945

Assessment of fecal output in patients receiving enteral tube feeding: validation of a novel chart.

K Whelan1, P A Judd, M A Taylor.   

Abstract

OBJECTIVE: To develop a practical, valid and reliable chart to assist in the accurate visual characterization of fecal output in patients receiving enteral tube feeding (ETF).
DESIGN: A chart incorporating verbal and pictorial descriptors of fecal output was developed. Validity and reliability were assessed by a questionnaire survey of health professionals and a clinical study of patients commencing ETF. Content validity was assessed from the results of the questionnaire, construct validity by contrasting groups analysis, concurrent validity by comparison of the chart with actual fecal weight and inter-rater reliability by independent characterization of the same fecal sample by two nurses.
SETTING: St George's Hospital, London, UK.
SUBJECTS: In all, 35 health professionals completed a questionnaire with respect to the chart. The chart was then used to monitor fecal output in 36 patients commencing ETF for a total of 171 patient-days, during which time nurses used the chart to characterize 269 fecal samples, of which 59 were subsequently weighed.
RESULTS: The results of the questionnaire suggested good content validity. The chart demonstrated statistically significant differences in fecal frequency, fecal consistency, fecal score and incidence of diarrhea for contrasting patient groups expected to have different fecal output (P < 0.05). The inter-rater reliability was almost perfect for fecal consistency (95% agreement, kappa = 0.91) and substantial for fecal weight (83%, kappa = 0.75). In all, 83% of fecal samples were assigned to the correct weight category (kappa = 0.75).
CONCLUSION: The chart has good content, construct and concurrent validity and inter-rater reliability, and is suitable for both research and clinical use. SPONSORSHIP: This research was jointly supported by King's College London and Nestlé, UK.

Entities:  

Mesh:

Year:  2004        PMID: 15220945     DOI: 10.1038/sj.ejcn.1601927

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  10 in total

1.  Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.

Authors:  Jeffrey H Burton; Matthew Johnson; Jolene Johnson; Daniel S Hsia; Frank L Greenway; Mark L Heiman
Journal:  J Diabetes Sci Technol       Date:  2015-03-23

2.  Evaluation of the effect of four fibers on laxation, gastrointestinal tolerance and serum markers in healthy humans.

Authors:  Maria L Stewart; Soma D Nikhanj; Derek A Timm; William Thomas; Joanne L Slavin
Journal:  Ann Nutr Metab       Date:  2010-01-19       Impact factor: 3.374

3.  Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study.

Authors:  Julio Plaza-Diaz; Carolina Gomez-Llorente; Laura Campaña-Martin; Esther Matencio; Inmaculada Ortuño; Rosario Martínez-Silla; Carlos Gomez-Gallego; Maria Jesús Periago; Gaspar Ros; Empar Chenoll; Salvador Genovés; Beatriz Casinos; Angela Silva; Dolores Corella; Olga Portolés; Fernando Romero; Daniel Ramón; Antonio Perez de la Cruz; Angel Gil; Luis Fontana
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

4.  Semi-solid feeds may reduce the risk of aspiration pneumonia and shorten postoperative length of stay after percutaneous endoscopic gastrostomy (PEG).

Authors:  Ezekiel Wong Toh Yoon; Kaori Yoneda; Kazuki Nishihara
Journal:  Endosc Int Open       Date:  2016-11-15

5.  A randomized controlled pilot study to evaluate the effect of an enteral formulation designed to improve gastrointestinal tolerance in the critically ill patient-the SPIRIT trial.

Authors:  Stephan M Jakob; Lukas Bütikofer; David Berger; Michael Coslovsky; Jukka Takala
Journal:  Crit Care       Date:  2017-06-10       Impact factor: 9.097

6.  Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study.

Authors:  Joanna C Dionne; Kristen Sullivan; Lawrence Mbuagbaw; Alyson Takaoka; Erick Huaileigh Duan; Waleed Alhazzani; John W Devlin; Matthew Duprey; Paul Moayyedi; David Armstrong; Lehana Thabane; Jennifer L Y Tsang; Roman Jaeschke; Cindy Hamielec; Tim Karachi; Rodrigo Cartin-Ceba; John Muscedere; Mohammed Saeed Saad Alshahrani; Deborah J Cook
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

7.  Validity of an observational assessment tool for multifaceted evaluation of faecal condition.

Authors:  Harumi Ohno; Haruka Murakami; Kumpei Tanisawa; Kana Konishi; Motohiko Miyachi
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

8.  Effects of a low-FODMAP enteral formula on diarrhea on patients in the intensive care unit.

Authors:  Eunjoo Bae; Jiyoon Kim; Jinyoung Jang; Junghyun Kim; Suyeon Kim; Youngeun Chang; Mi Yeon Kim; Mira Jeon; Seongsuk Kang; Jung Keun Lee; Tae Gon Kim
Journal:  Nutr Res Pract       Date:  2021-06-02       Impact factor: 1.926

9.  Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.

Authors:  So Ra Yoon; Jong Hwa Lee; Jae Hyang Lee; Ga Yoon Na; Kyun-Hee Lee; Yoon-Bok Lee; Gu-Hun Jung; Oh Yoen Kim
Journal:  Nutr J       Date:  2015-11-03       Impact factor: 3.271

10.  Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome.

Authors:  P Marquis; K E Lasch; L Delgado-Herrera; S Kothari; A Lembo; C Lademacher; G Spears; A Nishida; Waldman L Tesler; E Piault; K Rosa; B Zeiher
Journal:  Clin Transl Gastroenterol       Date:  2014-06-26       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.